Welcome to our dedicated page for TECOGEN SEC filings (Ticker: TGEN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TECOGEN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TECOGEN's regulatory disclosures and financial reporting.
Tecogen Inc. director Earl Lewis reported a stock option grant for 25,000 shares of common stock. The option has an exercise price of $5.17 per share and vests in equal 25% installments each year. It expires on June 26, 2036, and this grant brings his directly held derivative position to 25,000 options.
TECOGEN INC. director Ahmed Ghoniem received a grant of stock options giving the right to buy 25,000 shares of common stock. The options have an exercise price of $5.1700 per share and vest 25% per year. Following this grant, he holds 25,000 derivative securities directly, with these options exercisable beginning on June 26, 2027 and expiring on June 26, 2036.
Tecogen Inc. director Angelina Galiteva reported an equity compensation grant in the form of a stock option. She received options to buy 25,000 shares of common stock at an exercise price of $5.17 per share, vesting 25% per year.
The options become exercisable starting on June 26, 2027 and expire on June 26, 2036. After this grant, she holds stock options covering 25,000 underlying shares directly. This is a compensation-related award, not an open-market purchase or sale.
Tecogen Inc. reports that Portolan Capital Management, LLC and George McCabe each beneficially own 1,552,232 shares of Common Stock, representing 5.19% of the class. The filing states Portolan holds sole voting and dispositive power over these shares; Mr. McCabe is identified as the manager and reports indirect ownership.
Tecogen Inc. reported the results of its 2026 Annual Meeting of Stockholders. Shareholders elected seven directors to serve until the 2027 annual meeting or until successors are elected and qualified, including John M. Albertine, Angelina M. Galiteva, Ahmed F. Ghoniem, John N. Hatsopoulos, Susan F. Hirsch, Earl R. Lewis III, and Abinand Rangesh.
Stockholders also ratified the appointment of Wolf & Company, P.C. as independent registered public accountants for the fiscal year ending December 31, 2026. In advisory votes, a majority approved the compensation paid to named executive officers for 2025 and recommended holding say‑on‑pay votes every three years.
Tecogen Inc. reported weaker results for the quarter ended March 31, 2026. Revenue was $6.34 million, down from $7.28 million a year earlier, as product sales, especially cogeneration and chiller units, fell sharply while service and energy production revenue grew modestly.
Gross profit declined to $2.59 million, and higher general and administrative, selling, and R&D costs pushed the operating loss to $2.14 million versus $0.59 million last year. Net loss widened to $2.12 million, or $0.07 per share, compared with $0.03 per share.
Operating activities used $3.11 million of cash, driven by the larger loss, inventory build and higher receivables. Tecogen ended the quarter with $9.33 million in cash and cash equivalents and total assets of $34.46 million, supported by prior-period equity financing completed in 2025.
Tecogen Inc. reported weaker results for the quarter ended March 31, 2026. Revenue was $6.34 million, down from $7.28 million, as product sales fell sharply while services and energy production grew modestly. Net loss widened to $2.12 million, compared with a $0.66 million loss a year earlier, driven by lower gross profit and higher operating expenses.
Gross profit was $2.59 million with a margin of 40.9%, down from 44.3%. Operating expenses rose to $4.73 million as the company invested in its hybrid-drive chiller and data center initiatives. Adjusted EBITDA declined to negative $1.68 million from negative $0.38 million. Tecogen ended the quarter with $9.33 million in cash and cash equivalents and highlighted an expected 1 MW chiller purchase order from Vertiv and more than $8 million of customer-approved projects, including $2.3 million already under purchase order with deposits.
TECOGEN INC. director Ahmed Ghoniem reported new share ownership through an option exercise and related stock purchase. He completed an open-market purchase of 12,723 shares of common stock at $0.786 per share and exercised stock options for 12,723 shares at the same price. Following these transactions, he holds 12,723 common shares directly and no remaining options from this grant.
Tecogen Inc. is holding its 2026 Annual Meeting of Stockholders on June 5, 2026 at 1:00 p.m. in North Billerica, Massachusetts. Stockholders of record as of April 8, 2026, when 29,905,229 common shares were outstanding, may vote.
They will elect seven directors, ratify Wolf & Company, P.C. as independent auditor, and cast non-binding advisory votes on 2025 executive compensation and on how often to hold future say‑on‑pay votes, with the Board recommending “three years” for frequency. The proxy also details board committees, executive and director pay, ownership of large shareholders and insiders, and equity compensation plans.
TECOGEN INC. director Susan B. Hirsch reported an open-market purchase of 5,000 shares of the company’s Common Stock. The shares were bought at a price of $3.73 per share. After this transaction, she directly owns 265,416 Common Stock shares.